Impact of gsp oncogene on the expression of genes coding for G(s)α, Pit-1, G(i)2α, and somatostatin receptor 2 in human somatotroph adenomas: Involvement in octreotide sensitivity

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 8, 1999, Pages 2759-2765

  Barlier, Anne ^a   Pellegrini Bouiller, Isabelle ^a   Gunz, Ginette ^a   Zamora, Alfredo J ^a   Jaquet, Philippe ^a,b   Enjalbert, Alain ^a  

^a CNRS   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HUMAN; HYPOPHYSIS ADENOMA; MALE; NEGATIVE FEEDBACK; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC CELL; TUMOR VOLUME;

EID: 0033322617     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.8.5919     Document Type: Article

References (42)

1. Clinically nonfunctioning pituitary tumors are monoclonal in origin
2. Clonal origin of pituitary adenomas
3. Two G protein oncogene in human endocrine tumors
4. Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant G(s) protein
5. Glycoprotein hormone α-subunit production in somatotroph adenomas with and without G(s)α mutations
6. Pronostic and therapeutic consequences of Gsα mutations in somatotroph adenomas
7. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours
8. Biochemical characteristics of human pituitary somatotropinomas with and without gsp mutations: In vitro cell culture studies
9. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients
10. 3 cells of Gsα mutants associated with human pituitary tumors: Stimulation of adenosine 3',5'-monophosphate response element-binding protein-mediated transcription and of prolactin and growth hormone promoter activity via protein kinase A
11. Constitutively active G(s)α-subunits stimulate Pit-1 promoter activity via a protein kinase A-mediated pathway acting through deoxyribonucleic acid binding sites both for Pit-1 and for adenosine 3',5'-monophosphate response element-binding protein
12. Evidence for octreotide subcutaneously in the treatment of acromegaly
13. Gs protein mutations and pituitary tumors: Functional correlates and possible therapeutic implications
14. Clinical, Biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase
15. Decreased expression of the two D2 dopamine receptors isoforms in bromocriptine-resistant prolactinomas
16. Pit-1 gene expression in human lactotroph and somatotroph adenomas is correlated to D2 receptor gene expression
17. Alteration of Gα subunits mRNA levels in bromocriptine resistant prolactinomas
18. Molecular pharmacology of somatostatin receptor subtypes
19. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions
20. Pit-1 gene expression in the human pituitary and pituitary adenomas
21. S26 ribosomal protein RNA: An invariant control for gene regulation experiments in eucaryotic cells and tissues
22. Expression of somatostatin receptor subtypes in human brain tumors
23. Presence of three distinct molecular species of Gi protein α subunit. Structure of rat cDNAs and human genomic DNAs
24. Human cDNA clones for four species of Gαs signal transduction protein
25. The human genome encodes at least three non-allelic G proteins with αi-type subunits
26. Overexpression of stimulatory G protein α-subunit is a hallmark of most human somatotrophic pituitary tumours and is associated with resistance to GH-releasing hormone
27. Activating mutations of the G(s)α gene are associated with low levels of G(s)α protein in growth hormone-secreting tumors
28. Oncogenic role of heterotrimeric G proteins
29. Wang F-F. 1993 Correlation between prolactin secretion and Gs protein expression during sustained cholera-toxin stimulation
30. Cross-regulation between G-protein-mediated pathways. Stimulation of adenyl cyclase increases expression of the inhibitory G-protein, Giα2
31. Constitutively active G(s)α is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas
32. The cyclic adenosine 3',5'-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas
33. Increased expression of Gsα enhances activation of the adenylyl cyclase signal transduction cascade
34. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas
35. AP-1 and Oct-1 transcription factors down-regulate the expression of the human PIT-1/GHF-1 gene
36. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary
37. Heterogenous expression of two somatostatin receptor subtypes in pituitary tumors
38. Plasma Growth hormone responses to somatostatin (SRIH) receptors in pituitary adenomas in acromegalic patients
39. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status
40. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas
41. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas
42. Pituitary tumor pathogenesis